Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000780,serum leptin level,,,,5.46,ng/ml,1.06,2.8045,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67483,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000780,serum leptin level,,,,2.8,ng/ml,0.54,1.4287,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67484,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000780,serum leptin level,,,,6.28,ng/ml,0.51,1.6915,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67485,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000780,serum leptin level,,,,5.82,ng/ml,0.59,1.9568,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67486,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood leptin amount,,RS:0000284,OLETF,male,246 days,23,,CMO:0000780,serum leptin level,,,,10.87,ng/ml,0.5651,2.71,MMO:0000075,enzyme linked immunosorbent assay,carotid artery,0,"immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan",,,,fasting (for 18 hours),65739,fasting (for 18 hours),, 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood leptin amount,,RS:0000313,F344/NRrrc,male,246 days,21,,CMO:0000780,serum leptin level,,,,6.83,ng/ml,0.2379,1.09,MMO:0000075,enzyme linked immunosorbent assay,carotid artery,0,"immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan",,,,fasting (for 18 hours),65740,fasting (for 18 hours),, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood leptin amount,,RS:0000066,BB.WOKW-(D4Got41-Fabp1)/K,male,224 days,16,,CMO:0000780,serum leptin level,,,,7.7,ng/ml,2.1,8.4,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,67942,control condition,, 1035,"Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6.",blood leptin amount,,RS:0000625,OLETF/Got,male,112 days,25,,CMO:0000780,serum leptin level,,,,32.48,ng/ml,1.64,8.2,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68970,fasting (for 16 hours),, 1035,"Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6.",blood leptin amount,,RS:0000305,F344/DuCrlCrlj,male,112 days,15,,CMO:0000780,serum leptin level,,,,16.32,ng/ml,0.93,3.6019,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68971,fasting (for 16 hours),, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",blood leptin amount,,RS:0000065,WOKW,female,224 days to 196 days,12,,CMO:0000780,serum leptin level,,"average of measures taken at 196 days, 210 days and 224 days",serial mean,3.6,ng/ml,,,MMO:0000073,radioimmunoassay,ophthalmic venous plexus,0.0,"Roche Cobas Mira Plus (Roche, Switzerland)",,,,control condition,67917,control condition,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",blood leptin amount,,RS:0000243,DA/K,female,224 days to 196 days,12,,CMO:0000780,serum leptin level,,"average of measures taken at 196 days, 210 days and 224 days",serial mean,1.8,ng/ml,,,MMO:0000073,radioimmunoassay,ophthalmic venous plexus,0.0,"Roche Cobas Mira Plus (Roche, Switzerland)",,,,control condition,67918,control condition,, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood leptin amount,,RS:0000067,BB/OK,male,224 days,20,,CMO:0000780,serum leptin level,,,,7.7,ng/ml,1.7,7.6026,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,67940,control condition,, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood leptin amount,,RS:0000063,BB.SHR-(D4Got41-Tacr1)/K,male,224 days,20,,CMO:0000780,serum leptin level,,ng/ml,,15.3,ng/ml,3.5,15.6525,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,67941,control condition,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",blood leptin amount,,RS:0001087,WOKW/K,not specified,224 days to 196 days,12,,CMO:0000780,serum leptin level,,,,7.26,ng/ml,0.8487,2.94,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,96844,control condition,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",blood leptin amount,,RS:0000243,DA/K,not specified,224 days to 196 days,12,,CMO:0000780,serum leptin level,,,,2.61,ng/ml,0.2194,0.76,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,96845,control condition,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood leptin amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000780,serum leptin level,,,,1.67,ng/ml,0.37,0.9063,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101911,fasting (for 16 hours),, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood leptin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000780,serum leptin level,,,,53.97,ng/ml,2.34,6.1911,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101912,fasting (for 16 hours),,